Clinical and Translational Neuroscience Unit, Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medical College, United States.
Clinical and Translational Neuroscience Unit, Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medical College, United States.
J Clin Neurosci. 2021 Apr;86:180-183. doi: 10.1016/j.jocn.2021.01.008. Epub 2021 Jan 18.
Cerebrovascular complications among critically ill patients with COVID-19 have yet to be fully characterized. In this retrospective case series from a single academic tertiary care referral center in New York City, we present 12 patients with ischemic or hemorrhagic strokes that were found on imaging after a period of prolonged sedation in the setting of COVID-19 pneumonia. This series demonstrates a pattern of cerebrovascular events clinically masked by deep sedation required for management of COVID-19 related acute respiratory distress syndrome (ARDS). Of the 12 patients included, 10 had ischemic stroke, 4 of which had hemorrhagic conversion, and 2 had primary intracerebral hemorrhage. Ten patients were on therapeutic anticoagulation prior to discovery of their stroke, and the remainder received intermediate dose anticoagulation (in a range between prophylactic and therapeutic levels). Additional studies are needed to further characterize the counterbalancing risks of ischemic and hemorrhagic stroke, as well as the optimal management of this patient population.
COVID-19 危重症患者的脑血管并发症尚未得到充分描述。在这项来自纽约市一家学术性三级转诊中心的回顾性病例系列研究中,我们报告了 12 例 COVID-19 肺炎患者在长时间镇静后影像学检查发现缺血性或出血性脑卒中的病例。该系列研究表明,COVID-19 相关急性呼吸窘迫综合征(ARDS)管理所需的深度镇静掩盖了脑血管事件的临床表现。在纳入的 12 例患者中,10 例为缺血性脑卒中,其中 4 例发生出血性转化,2 例为原发性脑出血。10 例患者在发现脑卒中之前接受了抗凝治疗,其余患者接受了中等剂量抗凝治疗(介于预防和治疗水平之间)。需要进一步研究以更充分地描述缺血性和出血性脑卒中的权衡风险,以及此类患者人群的最佳管理方法。